Grazia Anna Niro

Summary

Affiliation: San Giovanni Rotondo
Country: Italy

Publications

  1. ncbi Current concept in the pathophysiology of hepatitis delta infection
    Grazia Anna Niro
    Division of Gastroenterology, Casa Sollievo della Sofferenza Hospital, IRCCS, Viale Cappuccini 1, 71013, San Giovanni Rotondo, FG, Italy
    Curr Infect Dis Rep 14:9-14. 2012
  2. ncbi Hepatitis delta virus infection: open issues
    Grazia Anna Niro
    Gastroenterology Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    Dig Liver Dis 43:S19-24. 2011
  3. ncbi Outcome of chronic delta hepatitis in Italy: a long-term cohort study
    Grazia Anna Niro
    Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, IRCCS, San Giovanni, Rotondo, Italy
    J Hepatol 53:834-40. 2010
  4. ncbi Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study
    G A Niro
    Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy
    Dig Liver Dis 39:857-63. 2007
  5. ncbi Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
    Grazia Anna Niro
    Gastroenterology CSS Hospital, S Giovanni Rotondo, and Gastroenterology Molinette Hospital and Unversity, Turin, Italy
    Hepatology 44:713-20. 2006
  6. ncbi Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study
    G A Niro
    Department of Gastroenterology, Hospital Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Italy
    Aliment Pharmacol Ther 22:227-32. 2005
  7. ncbi TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience
    Grazia Anna Niro
    Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy
    Ann N Y Acad Sci 1173:557-63. 2009
  8. ncbi Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis
    Angelo Iacobellis
    Division of Gastroenterology and Digestive Endoscopy, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy
    Clin Gastroenterol Hepatol 9:249-53. 2011
  9. ncbi Re-treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed after an initial course of lamivudine
    G A Niro
    Division of Gastroenterology, Hospital Casa Sollievo della Sofferenza IRCSS, San Giovanni Rotondo, Italy
    Aliment Pharmacol Ther 18:933-40. 2003
  10. ncbi Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection
    Grazia Anna Niro
    Department of Gastroenterology, Hospital Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    Liver Int 25:1175-81. 2005

Detail Information

Publications14

  1. ncbi Current concept in the pathophysiology of hepatitis delta infection
    Grazia Anna Niro
    Division of Gastroenterology, Casa Sollievo della Sofferenza Hospital, IRCCS, Viale Cappuccini 1, 71013, San Giovanni Rotondo, FG, Italy
    Curr Infect Dis Rep 14:9-14. 2012
    ..Beside the association between HDV/HBV and HCC is demonstrated a risk specifically related to HDV remains controversial...
  2. ncbi Hepatitis delta virus infection: open issues
    Grazia Anna Niro
    Gastroenterology Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    Dig Liver Dis 43:S19-24. 2011
    ..No specific inhibitors of HDV are available at present and, in spite of the crucial relationship between HDV and HBV, drugs that block HBV have only a theoretical but no sound effect on HDV replication...
  3. ncbi Outcome of chronic delta hepatitis in Italy: a long-term cohort study
    Grazia Anna Niro
    Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, IRCCS, San Giovanni, Rotondo, Italy
    J Hepatol 53:834-40. 2010
    ..To investigate the impact of HDV infection on morbidity and mortality of patients...
  4. ncbi Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study
    G A Niro
    Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy
    Dig Liver Dis 39:857-63. 2007
    ..We hypothesized that alternate rounds of lamivudine and alpha interferon might circumvent previous shortcomings...
  5. ncbi Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
    Grazia Anna Niro
    Gastroenterology CSS Hospital, S Giovanni Rotondo, and Gastroenterology Molinette Hospital and Unversity, Turin, Italy
    Hepatology 44:713-20. 2006
    ..Overall tolerance of therapy was poor...
  6. ncbi Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study
    G A Niro
    Department of Gastroenterology, Hospital Casa Sollievo della Sofferenza IRCCS, San Giovanni Rotondo, Italy
    Aliment Pharmacol Ther 22:227-32. 2005
    ..Delta virus (HDV)-related chronic hepatitis is difficult to treat...
  7. ncbi TNF-alpha polymorphisms in primary biliary cirrhosis: a northern and southern Italian experience
    Grazia Anna Niro
    Division of Gastroenterology, Casa Sollievo Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy
    Ann N Y Acad Sci 1173:557-63. 2009
    ..We report a distinct genetic risk of developing PBC in the Italian population, with no interaction between the HLA and TNF alleles...
  8. ncbi Long-term outcome after antiviral therapy of patients with hepatitis C virus infection and decompensated cirrhosis
    Angelo Iacobellis
    Division of Gastroenterology and Digestive Endoscopy, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy
    Clin Gastroenterol Hepatol 9:249-53. 2011
    ..We evaluated the long-term outcomes after antiviral therapy of patients with decompensated cirrhosis and hepatitis C virus (HCV) infection...
  9. ncbi Re-treatment of patients with anti-HBe-positive chronic hepatitis B who relapsed after an initial course of lamivudine
    G A Niro
    Division of Gastroenterology, Hospital Casa Sollievo della Sofferenza IRCSS, San Giovanni Rotondo, Italy
    Aliment Pharmacol Ther 18:933-40. 2003
    ....
  10. ncbi Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection
    Grazia Anna Niro
    Department of Gastroenterology, Hospital Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
    Liver Int 25:1175-81. 2005
    ..We evaluated the influence of tumor necrosis factor-alpha (TNF-alpha) promoter gene polymorphisms on clearance of hepatitis B virus (HBV) and outcome of HBV chronic hepatitis...
  11. ncbi Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients
    A Iacobellis
    Division of Gastroenterology, Casa Sollievo della Sofferenza Hospital, IRCCS, San Giovanni Rotondo 71013, Italy
    Aliment Pharmacol Ther 30:146-53. 2009
    ..Little data is available about predictors of sustained virological response (SVR) during anti-viral therapy of patients with decompensated HCV cirrhosis...
  12. ncbi Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies
    G A Niro
    Division of Gastroenterology, San Giovanni Battista Hospital, Turin, Italy
    Liver 21:254-9. 2001
    ..We evaluated the rate of seroclearance of the hepatitis B surface antigen (HBsAg) and its clinical significance in patients with chronic hepatitis delta virus (HDV)...
  13. ncbi Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
    F Perri
    Division of Gastroenterology, Casa Sollievo della Sofferenza Hospital, I R C C S, San Giovanni Rotondo, Italy
    Aliment Pharmacol Ther 15:1017-22. 2001
    ..Triple therapy with proton pump inhibitor, clarythromycin, and amoxicillin has been proposed in Maastricht as the first-line treatment of H. pylori infection...
  14. ncbi Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study
    Teresa Santantonio
    Department of Internal Medicine, Immunology and Infectious Diseases, University of Bari, Bari, Italy
    J Hepatol 36:799-804. 2002
    ..In this study, lamivudine-interferon (LAM/IFN) combination therapy was compared to LAM monotherapy to verify if the combination treatment might improve efficacy and reduce the emergence of LAM-resistant mutants...